Your browser doesn't support javascript.
loading
UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.
Carlini, Leslie E; Meropol, Neal J; Bever, John; Andria, Michael L; Hill, Todd; Gold, Philip; Rogatko, Andre; Wang, Hao; Blanchard, Rebecca L.
  • Carlini LE; Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111-2497, USA.
Clin Cancer Res ; 11(3): 1226-36, 2005 Feb 01.
Article en En | MEDLINE | ID: mdl-15709193
Search on Google
Banco de datos: MEDLINE Asunto principal: Polimorfismo Genético / Camptotecina / Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Glucuronosiltransferasa / Desoxicitidina Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2005 Tipo del documento: Article
Search on Google
Banco de datos: MEDLINE Asunto principal: Polimorfismo Genético / Camptotecina / Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Glucuronosiltransferasa / Desoxicitidina Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2005 Tipo del documento: Article